Grindeks AS operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other
pharmaceutical manufacturers in Europe:
Cathay International Holdings Ltd
of the United Kingdom
sales of £88.07 million [US$114.22 million]
Dottikon ES Holding AG
(121.43 million Swiss Francs [US$124.42 million]
of which 90%
was Pharma Products), and
(111.28 million Euro [US$124.47 million]
During the year ended December of 2016, sales at
Grindeks AS were 105.37 million Euro (US$117.86 million).
increase of 27.5%
versus 2015, when the company's sales were 82.66 million Euro.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Grindeks AS had sales
of 98.99 million Euro.